# Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx

> **NCT00243113** · PHASE2 · COMPLETED · sponsor: **Aichi Cancer Center** · enrollment: 50 (estimated)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** docetaxel
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00243113
- **Lead sponsor:** Aichi Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2008-03
- **Final completion:** 2008-11
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2013-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00243113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00243113, "Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00243113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*